THB ASSET MANAGEMENT - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 168 filers reported holding HAEMONETICS CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
THB ASSET MANAGEMENT ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2015$3,346,000
-42.4%
80,900
-37.4%
0.25%
-37.4%
Q1 2015$5,809,000
+132.7%
129,321
+93.8%
0.41%
+146.1%
Q4 2014$2,496,000
+55.5%
66,724
+45.1%
0.16%
+48.6%
Q3 2014$1,605,000
-37.2%
45,980
-25.6%
0.11%
-34.7%
Q2 2013$2,554,00061,7700.17%
Other shareholders
HAEMONETICS CORP shareholders Q3 2014
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders